FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

385123004: Conventional release eye ointment (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479385011 Eye ointment en Synonym Active Entire term case insensitive SNOMED CT core module
3620928015 Conventional release eye ointment (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3620929011 Conventional release eye ointment en Synonym Active Entire term case insensitive SNOMED CT core module
3620939017 Ophthalmic ointment en Synonym Active Entire term case insensitive SNOMED CT core module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release eye ointment Is a Type of drug preparation false Inferred relationship Existential restriction modifier
Conventional release eye ointment Is a Ointment false Inferred relationship Existential restriction modifier
Conventional release eye ointment Is a Ocular dose form true Inferred relationship Existential restriction modifier
Conventional release eye ointment Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release eye ointment Has dose form intended site Ocular true Inferred relationship Existential restriction modifier
Conventional release eye ointment Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release eye ointment Has basic dose form Ointment true Inferred relationship Existential restriction modifier
Conventional release eye ointment Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Liquid paraffin eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 25 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Polymyxin B sulfate+bacitracin zinc eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Polymyxin B sulfate+trimethoprim eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Hydrocortisone eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Simple eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Polymyxin B eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely sodium chloride 50 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Hydrocortisone acetate eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely atropine sulfate 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely aciclovir 30 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely propamidine isethionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely chloramphenicol 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely chlortetracycline hydrochloride 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely atropine sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Sulfacetamide 2.5% eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Sulfacetamide 10% eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Sulfacetamide 6% eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Prednisolone acetate + sulfacetamide sodium 0.5%ww/10%ww ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unit/3.5mg/10000unit ophthalmic ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Bacitracin zinc + polymyxin b sulfate 500unt/10000unt ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely prednisolone acetate 2 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely prednisolone acetate 2.5 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely vidarabine 30 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Gentamicin sulfate 0.3% ophthalmic ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely tobramycin 3 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Fluorometholone 0.1% ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Tetracycline hydrochloride 1% ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Conventional release ear or eye ointment Is a True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 60 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 25 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely fluorometholone acetate 1 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely wool alcohol 2 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 5 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely tetracycline hydrochloride 10 milligram/1 gram conventional release eye ointment (clinical drug) Has manufactured dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
SodiEye 6% eye ointment preservative free (TriOn Pharma Ltd) Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
SodiEye 6% eye ointment preservative free (TriOn Pharma Ltd) 5 gram Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely atropine sulfate 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 25 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely aciclovir 30 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely chlortetracycline hydrochloride 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely chloramphenicol 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely sodium chloride 50 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Sodium chloride 6% eye ointment preservative free Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Sodium chloride 6% eye ointment preservative free 5 gram Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Ciprofloxacin 3mg/g eye ointment (Special Order) Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Ciprofloxacin 3mg/g eye ointment (Special Order) 1 gram Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Ciprofloxacin 3mg/g eye ointment 1 gram Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Gentamicin 0.3% eye ointment Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Gentamicin 0.3% eye ointment 5 gram Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Gentamycin Augensalbe 0.3% eye ointment (medphano Arzneimittel GmbH) 5 gram Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Gentamycin Augensalbe 0.3% eye ointment (medphano Arzneimittel GmbH) Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely atropine sulfate 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely sodium chloride 50 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 25 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely chloramphenicol 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely chlortetracycline hydrochloride 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely aciclovir 30 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Aciclovir 3% eye ointment (CST Pharma Ltd) 4.5 gram Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Lacrilube eye ointment preservative free (AbbVie Ltd) 3.5 gram Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Aciclovir 3% eye ointment (CST Pharma Ltd) Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Lacrilube eye ointment preservative free (AbbVie Ltd) Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Aciclovir 3% eye ointment (Agepha Pharma s.r.o.) Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Aciclovir 3% eye ointment (Agepha Pharma s.r.o.) 4.5 gram Has dispensed dose form True Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely atropine sulfate 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 25 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely sodium chloride 50 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier
Product containing precisely aciclovir 30 milligram/1 gram conventional release eye ointment Has manufactured dose form False Conventional release eye ointment Inferred relationship Existential restriction modifier

Page 1 of 5 Next End

This concept is not in any reference sets

Back to Start